Cerebral amyloidoma is characterized by B ‐cell clonality and a stable clinical course

Brain Pathology,Volume 28, Issue 2, Page 234-239, March 2018.

Source: Brain Pathology - February 4, 2017 Category: Neurology Source Type: research